%0 Journal Article
%T Advocacy for Gender Affirming Care: Learning from the Injectable Estrogen Shortage
%A Kimberleigh Joy Smith
%A Sean Cahill
%A Sophia Geffen
%A Tim Horn
%J Archive of "Transgender Health".
%D 2018
%R 10.1089/trgh.2017.0025
%X Hormone therapy is medically necessary for many transgender individuals. The U.S. Food and Drug Administration (FDA) and pharmaceutical companies' failure to guarantee a supply of injectable estrogen in 2016 and 2017 for transgender individuals is a violation of their right to comprehensive medical treatment, free of discrimination. A series of advocacy actions eventually led to all formulations of injectable estrogen being restored to market; however, long-term solutions to supply interruptions of injectable estrogen are needed. Long-term solutions should address the lack of federally funded research and, consequently, evidence-based practice on hormone therapy for gender affirmation
%K public policy and advocacy
%K transgender
%K gender dysphoria
%K gender transition
%K clinical care
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908424/